Handelsbanken Fonder’s IDEAYA Biosciences IDYA Stock Holding History

Handelsbanken Fonder’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.27M	Buy	34,200 +3,300	+11%	+$101K	﹤0.01%	1023
2026 Q1	$1.03M	Hold	30,900	–	–	﹤0.01%	1026
2025 Q4	$1.07M	Sell	30,900 -6,100	-16%	-$194K	﹤0.01%	1001
2025 Q3	$1.01M	Buy	37,000 +10,300	+39%	+$249K	﹤0.01%	1001
2025 Q2	$561K	Sell	26,700 -7,600	-22%	-$146K	﹤0.01%	1199
2025 Q1	$562K	Buy	34,300 +9,000	+36%	+$192K	﹤0.01%	1198
2024 Q4	$650K	Buy	25,300 +1,900	+8%	+$53.8K	﹤0.01%	1181
2024 Q3	$741K	Hold	23,400	–	–	﹤0.01%	1073
2024 Q2	$822K	Buy	+23,400	New	+$927K	﹤0.01%	916

Other funds holding IDYA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Handelsbanken Fonder's IDYA Position: Q2 2026 in Review

Handelsbanken Fonder increased its IDEAYA Biosciences (IDYA) stake by 11% in Q2 2026, buying an estimated $101K and bringing the position to 34,200 shares worth $1.27M. The position accounts for ﹤0.01% of the portfolio, ranked #1023.

Handelsbanken Fonder first reported a position in IDYA in Q2 2024 and has held it in 9 quarters since. 285 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

Handelsbanken Fonder held 34,200 shares of IDEAYA Biosciences worth $1.27M as of Q2 2026.
Handelsbanken Fonder bought 3,300 IDEAYA Biosciences shares in Q2 2026, an estimated $101K.
IDEAYA Biosciences made up ﹤0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #1023 holding.
Handelsbanken Fonder first reported a position in IDEAYA Biosciences in Q2 2024 and has held it in 9 quarters since.
285 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.